Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex.
Neuropharmacology
; 180: 108297, 2020 12 01.
Article
in En
| MEDLINE
| ID: mdl-32890589
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tuberous Sclerosis
/
Epilepsies, Partial
/
Sirolimus
/
Everolimus
/
Mechanistic Target of Rapamycin Complex 1
/
Mechanistic Target of Rapamycin Complex 2
Limits:
Animals
Language:
En
Journal:
Neuropharmacology
Year:
2020
Document type:
Article
Affiliation country:
Germany
Country of publication:
United kingdom